Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | IDO1 | P14902 | 2/20 | 0.46 |
| ▸ | RXRA | P19793 | 1/20 | 0.46 |
| ▸ | RXRB | P28702 | 1/20 | 0.46 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.44 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 5/20 | 0.43 |
| ▸ | RAB9A | P51151 | 5/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | BCHE | P06276 | 2/20 | 0.42 |
| ▸ | ACHE | P22303 | 2/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | EGFR | P00533 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24506203 | 0.88 | NPC1 (0.44) | MEN1KMT2ALMNAPRSS1TPSAB1 | |
| SCHEMBL26502414 | 0.86 | MEN1 (0.49) | MEN1KMT2ALMNAIDO1RXRA | |
| SCHEMBL25978782 | 0.85 | MEN1 (0.48) | MEN1KMT2ALMNAIDO1RXRA | |
| SCHEMBL15592194 | 0.85 | MEN1 (0.51) | MEN1KMT2ALMNAIDO1RXRA | |
| SCHEMBL25749532 | 0.84 | LMNA (0.46) | MEN1KMT2ALMNAIDO1RXRA | |
| SCHEMBL21896174 | 0.84 | PRSS1 (0.49) | LMNAPRSS1TPSAB1NPC1RAB9A | |
| SCHEMBL21348178 | 0.84 | MEN1 (0.47) | MEN1KMT2ALMNAIDO1RXRA | |
| SCHEMBL16015346 | 0.83 | PRSS1 (0.48) | MEN1KMT2ARXRARXRBPRSS1 | |
| SCHEMBL23489098 | 0.82 | MEN1 (0.49) | MEN1KMT2ALMNAIDO1RXRA | |
| SCHEMBL16980507 | 0.82 | MEN1 (0.68) | MEN1KMT2ALMNARXRARXRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210170045-A1 | RELEASABLE ANTIBODY CONJUGATES | FISH & RICHARDSON PC | 2021-06-10 | — | — | US | disclosed |
| WO-2019171358-A1 | RELEASABLE ANTIBODY CONJUGATES | QUIAPEG PHARMACEUTICALS AB (SE) | 2019-09-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210170045-A1 | RELEASABLE ANTIBODY CONJUGATES | BCR, CD47, RNASE1 | MEN1 775/4885KMT2A 2325/4885LMNA 3509/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.